Search results
Results from the WOW.Com Content Network
Breath-holding spells (BHS) are the occurrence of episodic apnea in children, possibly associated with syncope (loss of consciousness and changes in postural tone).. Breath-holding spells occur in approximately 5% of the population with equal distribution between males and females.
ICD-10 is the 10th revision of the International Classification of Diseases (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [1]
Central sleep apnea due to high altitude periodic breathing 327.22 G47.32 Central sleep apnea due to a medical condition, not Cheyne-Stokes 327.27 G47.31 Central sleep apnea due to a drug or substance 327.29 F10-19 Primary sleep apnea of infancy 770.81 P28.3 Obstructive sleep apnea syndromes: Obstructive sleep apnea, adult 327.23 G47.33
Symptoms of sleep apnea include: Stops and starts in your breathing while sleeping. Loud snoring. Waking up with a snort, gasp, or choking sound. Waking up often to urinate.
Sleep apnea is measured by the apnea-hypopnea index (AHI). An AHI is determined with a sleep study. AHI values for adults are categorized as: [2] [3] Normal: AHI<5; Mild sleep apnea: 5≤AHI<15; Moderate sleep apnea: 15≤AHI<30; Severe sleep apnea: AHI≥30; An episode is when a person hesitates to breathe or stops their breathing altogether.
The conditions of hypoxia and hypercapnia, whether caused by apnea or not, trigger additional effects on the body.The immediate effects of central sleep apnea on the body depend on how long the failure to breathe endures, how short is the interval between failures to breathe, and the presence or absence of independent conditions whose effects amplify those of an apneic episode.
This is a shortened version of the sixteenth chapter of the ICD-9: Symptoms, Signs and Ill-defined Conditions. It covers ICD codes 780 to 799. The full chapter can be found on pages 455 to 471 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.